Cargando…

The role of systemic immuno-inflammatory factors in resectable pancreatic adenocarcinoma: a cohort retrospective study

BACKGROUND: Pancreatic cancer is an aggressive malignancy, surgery being the only potentially curative treatment. The systemic inflammatory response is an important factor in the development of cancer. There is still controversy regarding its role in pancreatic cancer. METHODS: Our study is a retros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlanger, D., Popa, C., Pașca, S., Seicean, A., Al Hajjar, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074307/ https://www.ncbi.nlm.nih.gov/pubmed/35513845 http://dx.doi.org/10.1186/s12957-022-02606-1

Ejemplares similares

Relationship between cachexia and perineural invasion in pancreatic adenocarcinoma
por: Petrusel, Livia, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on the training of general surgery residents: Surgical training and the COVID-19 pandemic
por: Popa, Călin, et al.
Publicado: (2022)

Inflammatory Ratios as Survival Prognostic Factors in Resectable Gastric Adenocarcinoma
por: Nechita, Vlad-Ionuţ, et al.
Publicado: (2023)

Emergency Pancreatoduodenectomy: A Non-Trauma Center Case Series
por: Schlanger, Diana, et al.
Publicado: (2022)

Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography
por: González-Gómez, Ruth, et al.
Publicado: (2021)

Neoadjuvant FOLFIRINOX Application in Borderline Resectable Pancreatic Adenocarcinoma: A Retrospective Cohort Study
por: Paniccia, Alessandro, et al.
Publicado: (2014)

Trends in Minimally Invasive Approaches for Liver Resections–A Systematic Review
por: Graur, Florin, et al.
Publicado: (2022)

Clinical Utility of the Contrast-Enhanced Endoscopic Ultrasound Guided Fine Needle Aspiration in the Diagnosis of Pancreatic Cyst
por: Olar, Miruna Patricia, et al.
Publicado: (2022)

THE ROLE OF IMMUNOINFLAMMATORY MARKERS IN THE PROGNOSIS AND RESECTABILITY OF PANCREATIC ADENOCARCINOMA
por: EYFF, Tatiana Falcão, et al.
Publicado: (2018)

Clinical Predictors of Resectability of Pancreatic Adenocarcinoma
por: Almadi, Majid A., et al.
Publicado: (2013)

Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study
por: Zou, Siyi, et al.
Publicado: (2022)

The impact of resection margin distance on survival and recurrence in pancreatic ductal adenocarcinoma in a retrospective cohort analysis
por: Obonyo, Dennis, et al.
Publicado: (2023)

Palliative Resection of Pancreatic Adenocarcinoma
por: Johnson, C. D.
Publicado: (1995)

Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas
por: Botsis, Taxiarchis, et al.
Publicado: (2010)

Predictive factors for resection and survival in type A borderline resectable pancreatic ductal adenocarcinoma patients after neoadjuvant therapy: A retrospective cohort study
por: Secanella, Luis, et al.
Publicado: (2022)

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Salmiheimo, Aino, et al.
Publicado: (2016)

Extended Venous Resections for Borderline Resectable Pancreatic Head Adenocarcinoma—A Retrospective Studies of Nine Cases
por: Bacalbasa, Nicolae, et al.
Publicado: (2021)

Surgical resectability of pancreatic adenocarcinoma: CTA
por: Wong, Jimmie C., et al.
Publicado: (2009)

Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
por: Trinh, Katherine V., et al.
Publicado: (2020)

Significance of pulmonary resection in patients with metachronous pulmonary metastasis from pancreatic ductal adenocarcinoma: a retrospective cohort study
por: Mashiko, Taro, et al.
Publicado: (2021)

Endoscopic therapy in chronic pancreatitis: current perspectives
por: Seicean, Andrada, et al.
Publicado: (2014)

Is There a Role for Intraoperative Radiation Therapy in Patients with Resected Pancreatic Adenocarcinoma?
por: Meyer, Jeffrey J., et al.
Publicado: (2009)

Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
por: Vernuccio, Federica, et al.
Publicado: (2021)

Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor
por: Westgaard, Arne, et al.
Publicado: (2008)

Multivisceral resection for adenocarcinoma of the pancreatic body and tail—a retrospective single-center analysis
por: Beetz, Oliver, et al.
Publicado: (2020)

Endoscopic ultrasound drainage of pancreatic fluid collections: do we know enough about the best approach?
por: Seicean, Andrada, et al.
Publicado: (2023)

Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: a retrospective cohort study
por: Wen, Chenlei, et al.
Publicado: (2023)

The role of the immuno-inflammatory response in patients after cardiac arrest
por: Samborska-Sablik, Anna, et al.
Publicado: (2011)

Role of Immuno-Inflammatory Signals in Liver Ischemia-Reperfusion Injury
por: Kaltenmeier, Christof, et al.
Publicado: (2022)

Dishevelled-Associated Activator of Morphogenesis 2 (DAAM2) Predicts the Immuno-Hot Phenotype in Pancreatic Adenocarcinoma
por: Zhang, Qinglin, et al.
Publicado: (2022)

Resected pancreatic adenocarcinoma: An Asian institution's experience
por: Ng, Kennedy Yao Yi, et al.
Publicado: (2021)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

The Role of IL-22 in Wound Healing. Potential Implications in Clinical Practice
por: Zaharie, Roxana Delia, et al.
Publicado: (2022)

Surgical management of hydatid cyst disease of the liver: An improvement from our previous experience?
por: Zaharie, Florin, et al.
Publicado: (2023)

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
por: Hosein, Peter J, et al.
Publicado: (2012)

Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma
por: Agrawal, Shefali
Publicado: (2017)

The effects of systemic inflammatory response on prognosis of pancreatic ductal adenocarcinoma
por: Aktekin, Ali, et al.
Publicado: (2019)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Resectability of the pancreatic adenocarcinoma: A study from Iran
por: Baghbanian, Mahmud, et al.
Publicado: (2014)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
por: Flis, Vojko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d5k7v2k33ghckqi10mtr6676h4